Christopher Kling, MD
Dermatology · Wildwood, MONPI 1467449934
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $24,270 of the $33,065 with a category attached, or 73.4%. It is spread thinly across 45 manufacturers, the largest accounting for just 21.8%. Among dermatology clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,715 payments — averaging $19.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$7K
- UCB, Inc.$4K
- Johnson & Johnson$2K
- Almirall LLC$2K
- Lilly USA, LLC$2K
- Sun Pharmaceutical Industries Inc.$1K
- plus $15K from 39 others
Across 54 payments — averaging $1960.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Incyte Corporation$83K
- AbbVie$23K
What the payments were for
- Consulting fees$5,25016%
- Speaking & faculty fees$2,7008%
- Travel & lodging$230%
- Food & beverage$24,27073%
- Education$8212%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$33,065 in reported general payments places this provider in the 90th percentile of 263 dermatology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 13 | $177,104 |
| Dupixent PenDupilumab | 15 | $55,615 |
| Dupixent SyringeDupilumab | 13 | $48,232 |
| Clobetasol Propionate | 111 | $6,677 |
| Betamethasone Dipropionate | 138 | $6,004 |
| Ketoconazole | 295 | $4,768 |
| Doxycycline Hyclate | 149 | $2,712 |
| Triamcinolone Acetonide | 216 | $2,474 |
| Metronidazole | 47 | $2,053 |
| Clindamycin Phosphate | 23 | $1,818 |
| Hydrocortisone | 241 | $1,561 |
| ValacyclovirValacyclovir Hcl | 54 | $1,400 |
| Tretinoin | 15 | $1,334 |
| Fluocinonide | 37 | $1,295 |
| Econazole Nitrate | 37 | $1,198 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Wildwood
- Brian KimSaint Louis$861K
- Elaine SiegfriedSaint Louis$856K
- Craig LeonardiSaint Louis$569K
- Jonathan CleaverKirksville$483K
- Mary GeorgeSaint Louis$400K
- David CleaverKirksville$371K
- Christy RaineyBranson$328K
- Charles MoonCape Girardeau$296K
- John DespainOsage Beach$289K
- Duane DilworthSaint Louis$288K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.